Although we found that nine CpG sites in CRISP2 identified in blood were significantly and positively correlated with both the PFC and STG regions (Supplementary Fig. S8), the expression levels of CRISP2 in the brain from WS patients remain unknown. This evidence concerns the gene CRISP2 and Werner syndrome.